Sage Sees New Diagnosis Trend In PPD As Zurzuvae Launch Gets Off The Ground

It’s early days in the launch of Zurzuvae for postpartum depression, but Sage highlighted encouraging prescription trends during the company’s fourth quarter sales and earnings call.